Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
about
Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapyThen and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspectiveCell-cell and cell-matrix dynamics in intraperitoneal cancer metastasisPeritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal ChemotherapyWhole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice.Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?Netrin-4 delays colorectal cancer carcinomatosis by inhibiting tumor angiogenesis.Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)Desmoplastic small round cell tumor: current management and recent findings.Laparoscopic Confocal Laser Microscopy Without Fluorescent Injection: A Pilot Ex Vivo Study in Colon Cancer.Results of multimodal treatment for desmoplastic small round cell tumor of the abdomen and pelvis.Cytoreductive surgery in ovarian cancer.High-quality results of cytoreductive surgery and heated intraperitoneal chemotherapy perfusion for carcinomatosis at a low volume institution.Computerized System for Staging Peritoneal Surface MalignanciesA contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion.The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy.Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapyIntraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.Surgical treatment of peritoneal carcinomatosis: current treatment modalities.Testicular desmoplastic small round cell tumor: a case report and review of literature.Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.Management of Inguinal Involvement of Peritoneal Surface Malignancies by Cytoreduction and HIPEC with Inguinal PerfusionDiagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies.A review of 111 anaesthetic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Desmoplastic small round cell tumor 20 years after its discovery.Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery.The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score.Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction.The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.[Morbidity and mortality of hyperthermic intraperitoneal chemoperfusion].Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC.Analysis of clinicopathological features and prognostic factors of desmoplastic small round cell tumor.
P2860
Q26768400-B5926AE5-A7DF-42EC-B9D0-788F657DFCEBQ26768408-15DC8C11-D82B-4BFD-8EC6-163524B3021DQ26851836-1C85EC8A-7B02-47D4-BAC3-ED171E3D3FB6Q31031044-081A51EC-0866-4ED8-86FE-596FB43F5545Q33398380-CAEA6C25-E134-4EE4-88BE-39D1EE2B164EQ33457159-4F652504-E9B6-4326-9CA4-CB6AE6628C2DQ33874451-CF484F99-387A-4730-9B0A-5CB262603F8BQ34130132-37097738-E111-48F3-80B2-591330E5B595Q34366940-56764ABD-2720-4108-88CD-A45C75B14940Q34805721-354D1088-B0C1-4DBD-A747-87ADF33D9A52Q35680294-63A8FACE-D326-4ACD-BA31-9193EAEC4EDCQ35898508-72714885-9BD6-473C-8117-6C1EFE59AACFQ35956976-66EBA4A4-6C6C-4B34-B5B1-16D62C6FF4AFQ35959507-EEF81DBE-825E-41C5-9ACD-CA9654499AF5Q36295219-584400E3-418C-49A7-A8EC-0080E342B32EQ36306819-F1C44799-32D4-49F6-8693-64CB77006AE9Q36762307-D207802C-2AA2-4CB6-B5D7-B3476505EB38Q36977424-79F28495-BFEB-4C45-A37C-B652F3246571Q37114979-348AB8C2-840B-46FE-9BAF-3B4845B84AC7Q37291528-D70635EE-4D56-4764-B225-DA3B62ED559BQ37662806-AA1D8265-A267-43C1-80A0-F4ACB65DB6F3Q37714442-C7D43BC5-00CA-471C-A388-C530F90B004AQ38163913-D0AB40D0-EACE-4049-BE7D-EB6DFD2C615BQ38231117-727206C6-3326-4AF8-83F7-879352EFCD9EQ38244051-FB775633-5EAF-4BE0-97F6-9289840E1D9AQ38348848-C4D7C25C-07A5-4AA7-B931-03389F01E3DAQ38804709-B1661B64-0697-466E-AC5D-0939D2B03927Q38819415-BD01A69F-B5CC-4CE6-B9A0-F04E28E08CA8Q39025917-EB977E43-5420-49D9-B49A-E0B489C1D851Q39246331-F5F798BF-28FD-4C8E-BC34-E4214737152FQ40312433-876D9386-17FE-4666-8BF3-160F366A73D8Q40350439-2AEB209F-18C9-4776-AA75-3C28C80B2634Q40507435-94C51EEB-21E5-4AC4-921D-682C28AFD26EQ40971331-4536E8CA-74EB-429B-9948-769835921CBEQ41047329-7A88A577-F483-401A-9D52-67C2501C6F30Q41462800-07960939-3230-406A-AF29-F81E932ED08AQ43580584-A70A1951-094D-41E3-A072-224712FA6BB6Q43588648-AE6FED21-91D9-401C-8BB3-167ED4C169D1Q43735451-EBC12727-D59B-42DC-B9A5-E3473E130DB7Q43957575-5DFC8B98-BBA1-4DF7-8E01-0C983F62AAA4
P2860
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@ast
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@en
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@nl
type
label
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@ast
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@en
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@nl
prefLabel
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@ast
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@en
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@nl
P2860
P3181
P356
P1476
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
@en
P2093
Paul H Sugarbaker
Rhonda L Harmon
P2860
P2888
P3181
P356
10.1186/1477-7800-2-3
P577
2005-02-08T00:00:00Z
P5875
P6179
1000978172